Clinical Trial
Also known as: Clinical study, Human trial, Drug trial
Clinical Trial is a research study conducted in human participants to evaluate the safety and efficacy of a medical intervention such as a new drug, treatment, or device. Clinical trials follow strict protocols and progress through phases (I-IV) before a drug can receive regulatory approval for widespread use.
Last updated: January 21, 2026
Phases of Clinical Trials
Phase I: Safety and Dosing
| Aspect | Details |
|---|---|
| Participants | 20-100 healthy volunteers |
| Duration | Several months |
| Purpose | Safety, dosing, side effects |
| Key question | Is it safe? |
Phase II: Efficacy Exploration
| Aspect | Details |
|---|---|
| Participants | 100-300 patients with condition |
| Duration | Several months to 2 years |
| Purpose | Effectiveness, optimal dose |
| Key question | Does it work? |
Phase III: Confirmation
| Aspect | Details |
|---|---|
| Participants | 1,000-3,000+ patients |
| Duration | 1-4 years |
| Purpose | Confirm efficacy, monitor side effects |
| Key question | Is it better than existing treatments? |
Phase IV: Post-Marketing
| Aspect | Details |
|---|---|
| Participants | General population |
| Duration | Ongoing |
| Purpose | Long-term safety, rare side effects |
| Key question | What happens in real-world use? |
Clinical Trial Design Elements
Randomization
- Participants randomly assigned to groups
- Reduces selection bias
- Ensures comparable groups
Control Group
- Receives placebo or standard treatment
- Provides comparison baseline
- Essential for measuring true effect
Blinding
- Single-blind: Participant doesn’t know assignment
- Double-blind: Neither participant nor researcher knows
- Triple-blind: Data analysts also blinded
Landmark Peptide Clinical Trials
STEP Trials (Semaglutide for Weight)
- Studied semaglutide 2.4mg for obesity
- STEP 1: 15% weight loss vs placebo
- Led to Wegovy approval
SURPASS Trials (Tirzepatide)
- Compared tirzepatide to competitors
- Showed superior A1C and weight outcomes
- Led to Mounjaro/Zepbound approvals
SURMOUNT Trials (Tirzepatide for Obesity)
- Weight management focused
- Up to 22% weight loss
- Supported Zepbound approval
Understanding Trial Results
Key Metrics
| Metric | Meaning |
|---|---|
| p-value | Statistical significance (typically <0.05) |
| Confidence interval | Range likely containing true effect |
| Effect size | Magnitude of difference |
| NNT | Number needed to treat for one benefit |
| NNH | Number needed to harm for one adverse event |
Interpreting Results
- Statistically significant ≠ clinically meaningful
- Look at absolute differences, not just percentages
- Consider the population studied
Limitations of Clinical Trials
| Limitation | Impact |
|---|---|
| Selected population | May not represent all patients |
| Limited duration | Long-term effects unknown |
| Controlled conditions | Real-world use may differ |
| Exclusion criteria | Certain groups not studied |
Frequently Asked Questions
How long does drug approval take?
From initial research to approval typically takes 10-15 years. Clinical trial phases alone take 6-7 years on average. Expedited pathways can shorten this for drugs treating serious conditions.
What happens if a trial fails?
Failed trials can end drug development or lead to redesigned studies. A drug might fail to show benefit, have unacceptable side effects, or not outperform existing treatments. Most drug candidates never reach approval.
Can I participate in a clinical trial?
Yes, if you meet eligibility criteria. ClinicalTrials.gov lists ongoing studies. Participation involves informed consent, careful monitoring, and potential access to new treatments. Discuss with your healthcare provider.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.